XPA and xeroderma pigmentosum: This nonsense mutation occurs in the C-terminal domain of XPA protein, and this could explain the moderate clinical manifestations of our XP group A patients; since the severity of the clinical phenotype is observed when mutations are located in the DNA binding region (aa 98–219) (Fig. 2).